Cysticercus is a common food-borne zoonotic parasite, the larvae of the tapeworm. Humans can be infested by adult cysticerci and also by their larvae. There are various species of Cysticercus parasiticus in animals, and those transmitted to humans through meat include porcine Cysticercus and bovine Cysticercus, with porcine Cysticercus being more common. According to the parasitic site of cysticerci, cysticercosis is divided into subcutaneous and muscular cysticerci, cerebral cysticerci, ocular cysticerci, cysticerci of other parts and mixed cysticerci, among which cerebral cysticerci cause the most serious damage to human body. At the same time, the animal meat discarded every year due to contamination by cysticercosis also causes huge losses to the rural economy.
Ace Therapeutics specializes in parasitology research and has established a parasite testing technology platform to provide high quality porcine Cysticercus testing services. In order to study in depth the morphology, life history (ecology), pathogenesis, epidemiological patterns and immunogenetic characteristics of porcine Cysticercus.
Ace Therapeutics provides high quality porcine Cysticercus testing services, service options include, but are not limited to:
Pathogenetic testing service for porcine Cysticercus |
|
Immunological testing service for porcine Cysticercus |
|
Molecular biology testing service for porcine Cysticercus |
|
Applicable samples: import and export animals, humans, carnivorous mammals (dogs, cats, etc.) and freshwater snails, freshwater fish and shrimps, etc.
Test items: Pressed film testing, Cysticercus incubation testing, tissue biopsies, indirect ELISA testing, Dot-ABC-ELISA testing, FTA testing, etc.
Delivery content: test report
Test fee: please get it through online inquiry
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.